LIFEVANTAGE CORP (LFVN) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $138.92M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-1.87M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $138.73M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-1.73M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $138.04M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-1.61M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $137.65M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-1.35M.
LIFEVANTAGE CORP Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $1.00K | $138.92M | $-1.87M | $-103.46M | $33.59M | 12 month · $2.35M | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $1.00K | $138.73M | $-1.73M | $-103.66M | $33.34M | 3 month · $704.00K | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $1.00K | $138.04M | $-1.61M | $-103.44M | $32.99M | 3 month · $553.00K | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $1.00K | $137.65M | $-1.35M | $-103.14M | $33.16M | 3 month · $826.00K | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $1.00K | $139.96M | $-1.18M | $-104.15M | $34.64M | 12 month · $5.70M | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $1.00K | $139.07M | $-1.55M | $-103.51M | $34.01M | 3 month · $1.52M | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $1.00K | $138.17M | $-1.80M | $-106.48M | $29.89M | 3 month · $1.72M | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $1.00K | $137.35M | $-1.12M | $-108.53M | $27.70M | 3 month · $917.00K | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $1.00K | $136.64M | $-1.92M | $-108.74M | $25.99M | 12 month · $3.28M | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $1.00K | $136.20M | $-1.72M | $-107.71M | $26.77M | 3 month · $796.00K | 3 month · $800.00K 9 month · $2.50M | (m) | (m) |
| 2023-12-31 | $0.00 | $1.00K | $135.49M | $-1.19M | $-106.99M | $27.31M | 3 month · $750.00K | 3 month · $800.00K 6 month · $1.70M | (m) | (m) |
| 2023-09-30 | $0.00 | $1.00K | $134.95M | $-1.66M | $-104.00M | $29.29M | 3 month · $978.00K | 3 month · $1.00M | (m) | (m) |
| 2023-06-30 | $0.00 | $1.00K | $134.31M | $-1.36M | $-98.31M | $34.65M | 12 month · $3.19M | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $1.00K | $133.42M | $-979.00K | $-99.00M | $33.44M | 3 month · $817.00K | 3 month · $800.00K 9 month · $2.20M | (m) | (m) |
| 2022-12-31 | $0.00 | $1.00K | $132.53M | $-993.00K | $-99.64M | $31.89M | 3 month · $823.00K | 3 month · $800.00K 6 month · $1.40M | (m) | (m) |
| 2022-09-30 | $0.00 | $1.00K | $131.73M | $-1.63M | $-98.20M | $31.89M | 3 month · $602.00K | 3 month · $600.00K | (m) | (m) |
| 2022-06-30 | $0.00 | $1.00K | $131.07M | $-1.12M | $-98.44M | $31.52M | 12 month · $1.77M | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | $1.00K | $130.71M | $-500.00K | $-96.18M | $34.03M | 3 month · $-38.00K | 3 month · $-38.00K 9 month · $1.40M | (m) | (m) |
| 2021-12-31 | $0.00 | $1.00K | $130.59M | $-210.00K | $-95.60M | $34.78M | 3 month · $755.00K | 3 month · $800.00K 6 month · $1.40M | (m) | (m) |
| 2021-09-30 | $0.00 | $1.00K | $129.86M | $-31.00K | $-92.52M | $37.31M | 3 month · $645.00K | 3 month · $600.00K | (m) | (m) |
| 2021-06-30 | $0.00 | $1.00K | $129.05M | $104.00K | $-92.35M | $36.81M | 12 month · $2.15M | (m) | (m) | (m) |
| 2021-03-31 | $0.00 | $1.00K | $128.84M | $105.00K | $-93.32M | $35.63M | 3 month · $684.00K | 3 month · $700.00K 9 month · $2.20M | (m) | (m) |
| 2020-12-31 | $0.00 | $1.00K | $128.01M | $548.00K | $-93.04M | $35.52M | 3 month · $999.00K | 3 month · $1.00M 6 month · $1.50M | (m) | (m) |
| 2020-09-30 | $0.00 | $1.00K | $126.69M | $304.00K | $-92.86M | $34.14M | 3 month · $520.00K | 3 month · $500.00K | (m) | (m) |
| 2020-06-30 | $0.00 | $1.00K | $126.42M | $144.00K | $-93.31M | $33.25M | 12 month · $4.84M | (m) | (m) | (m) |
| 2020-03-31 | $0.00 | $1.00K | $125.70M | $32.00K | $-97.13M | $28.60M | 3 month · $1.19M | 3 month · $1.20M 9 month · $4.00M | (m) | (m) |
| 2019-12-31 | $0.00 | $1.00K | $125.86M | $32.00K | $-96.79M | $29.10M | 3 month · $1.50M | 3 month · $1.40M 6 month · $2.70M | (m) | (m) |
| 2019-09-30 | $0.00 | $1.00K | $128.66M | $46.00K | $-99.08M | $29.62M | 3 month · $1.28M | 3 month · $1.30M | (m) | (m) |
| 2019-06-30 | $0.00 | $1.00K | $127.10M | $62.00K | $-99.96M | $27.20M | 12 month · $4.90M | (m) | (m) | (m) |
| 2019-03-31 | $0.00 | $1.00K | $125.69M | $-32.00K | $-100.92M | $24.75M | 3 month · $2.01M | 3 month · $1.00M 9 month · $3.60M | (m) | (m) |
| 2018-12-31 | $0.00 | $1.00K | $123.50M | $10.00K | $-102.49M | $21.02M | 3 month · $999.00K 6 month · $629.00K | 3 month · $1.00M 6 month · $1.60M | (m) | (m) |
| 2018-09-30 | $0.00 | $1.00K | $125.46M | $-111.00K | $-101.82M | $23.53M | 3 month · $629.00K | 3 month · $600.00K | (m) | (m) |
| 2018-07-01 | (m) | (m) | (m) | (m) | (m) | $21.94M | (m) | (m) | (m) | (m) |
| 2018-06-30 | $0.00 | $1.00K | $124.66M | $14.00K | $-102.73M | $21.95M | 12 month · $2.99M | (m) | (m) | (m) |
| 2018-03-31 | $0.00 | $1.00K | $123.95M | $69.00K | $-104.72M | $19.30M | 9 month · $2.31M | 3 month · $1.30M 9 month · $2.30M | (m) | (m) |
| 2017-12-31 | $0.00 | $14.00K | $122.63M | $-28.00K | $-106.11M | $16.50M | 6 month · $1.03M | 3 month · $600.00K 6 month · $1.00M | (m) | (m) |
| 2017-09-30 | $0.00 | $14.00K | $122.01M | $-74.00K | $-106.17M | $15.77M | 3 month · $408.00K | 3 month · $400.00K | (m) | (m) |
| 2017-06-30 | $0.00 | $14.00K | $121.60M | $-94.00K | $-106.99M | $14.53M | 12 month · $2.31M | (m) | (m) | (m) |
| 2017-03-31 | $0.00 | $14.00K | $120.46M | $-29.00K | $-106.55M | $13.89M | 9 month · $1.65M | 3 month · $600.00K 9 month · $1.70M | (m) | (m) |
| 2016-12-31 | $0.00 | $14.00K | $121.17M | $-55.00K | $-106.61M | $14.51M | 6 month · $1.01M | 3 month · $300.00K 6 month · $1.00M | (m) | (m) |
| 2016-09-30 | $0.00 | $14.00K | $120.83M | $134.00K | $-106.90M | $14.08M | 3 month · $675.00K | 3 month · $700.00K | (m) | (m) |
| 2016-06-30 | $0.00 | $14.00K | $119.24M | $-7.00K | $-108.60M | $10.65M | 12 month · $1.97M | (m) | (m) | (m) |
| 2016-03-31 | $0.00 | $14.00K | $119.37M | $-123.00K | $-110.43M | $8.84M | 9 month · $1.25M | 3 month · $700.00K 9 month · $1.20M | (m) | (m) |
| 2015-12-31 | $0.00 | $14.00K | $118.65M | $-225.00K | $-111.43M | $7.01M | 6 month · $503.00K | 3 month · $300.00K 6 month · $500.00K | (m) | (m) |
| 2015-09-30 | $0.00 | $14.00K | $117.83M | $-234.00K | $-113.03M | $4.58M | 3 month · $188.00K | 3 month · $200.00K | (m) | (m) |
| 2015-06-30 | $0.00 | $14.00K | $117.66M | $-251.00K | $-114.09M | $1.81M | 12 month · $1.74M | (m) | (m) | (m) |
| 2015-03-31 | $0.00 | $97.00K | $117.25M | $-194.00K | $-114.32M | $2.83M | 9 month · $1.43M | 3 month · $600.00K 9 month · $1.40M | (m) | (m) |
| 2014-12-31 | $0.00 | $99.00K | $116.30M | $-195.00K | $-111.66M | $4.55M | 6 month · $862.00K | 3 month · $500.00K 6 month · $900.00K | (m) | (m) |
| 2014-09-30 | $0.00 | $101.00K | $115.68M | $-59.00K | $-108.52M | $7.20M | 3 month · $398.00K | 3 month · $400.00K | (m) | (m) |
| 2014-06-30 | $0.00 | $102.00K | $115.24M | $-116.00K | $-111.24M | $2.33M | 12 month · $2.61M | (m) | (m) | (m) |
| 2014-03-31 | $0.00 | $104.00K | $113.69M | $-476.00K | $-110.59M | $2.73M | 9 month · $2.04M | 3 month · $600.00K 9 month · $2.00M | (m) | (m) |
| 2013-12-31 | $0.00 | $104.00K | $113.01M | $-579.00K | $-113.09M | $-548.00K | 6 month · $1.45M | 3 month · $700.00K 6 month · $1.50M | (m) | (m) |
| 2013-09-30 | $0.00 | $118.00K | $111.43M | $-387.00K | $-76.08M | $35.08M | 3 month · $768.00K | 3 month · $800.00K | (m) | (m) |
| 2013-06-30 | $0.00 | $121.00K | $110.41M | $-113.00K | $-76.48M | $33.95M | 12 month · $2.17M | (m) | 12 month · $0.00 | (m) |
| 2013-03-31 | $0.00 | $116.00K | $108.85M | $-45.00K | $-74.06M | $34.86M | (m) | 3 month · $600.00K 9 month · $1.60M | (m) | (m) |
| 2012-12-31 | (m) | $115.00K | $107.70M | $42.00K | $-72.83M | $35.03M | (m) | 3 month · $600.00K 6 month · $1.10M | (m) | (m) |
| 2012-09-30 | (m) | $114.00K | $106.83M | $-26.00K | $-72.80M | $34.12M | (m) | 3 month · $500.00K | (m) | (m) |
| 2012-06-30 | $0.00 | $111.00K | $105.15M | $-21.00K | $-76.96M | $28.28M | 12 month · $1.32M | (m) | 12 month · $16.48M | (m) |
| 2012-03-31 | (m) | $109.90K | $104.26M | $-47.60K | $-81.79M | $22.53M | (m) | 3 month · $308.00K 9 month · $881.00K | 9 month · $16.48M | 9 month · $-309.56K |
| 2011-12-31 | (m) | $100.29K | $85.82M | $32.68K | $-76.62M | $9.33M | (m) | 3 month · $218.00K 6 month · $573.00K | 6 month · $16.48M | (m) |
| 2011-09-30 | (m) | $99.28K | $68.40M | $24.43K | $-84.73M | $-16.20M | (m) | 3 month · $355.00K | (m) | (m) |
| 2011-06-30 | (m) | $98.80K | $67.61M | $-59.68K | $-88.45M | $-20.81M | 12 month · $766.00K | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | $-16.18M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |